
|Videos|August 1, 2017
Second-Line Therapy Options in Metastatic Renal Cell Carcinoma
Author(s)Neeraj Agarwal, MD
This video reviews the various treatment options for metastatic renal cell carcinoma in the second-line setting, including considerations for different toxicity profiles.
Advertisement
In this video, Neeraj Agarwal, MD, of the University of Utah Huntsman Cancer Institute, reviews the various treatment options for metastatic renal cell carcinoma in the second-line setting, including considerations of the different toxicity profiles.
Agarwal spoke on this topic at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel Cancer Vaccine Receives FDA Orphan Drug Designation in Cutaneous Melanoma
2
Exploring The Application of Artificial Intelligence in Radiology Scans
3
FDA Accepts NDA for Rivoceranib and Camrelizumab in 1L Unresectable HCC
4
Apalutamide Reduces Risk of Death by 51% in Metastatic CSPC
5


































